At close: 4:00:00 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CHEVALLARD DANIEL R Chief Operating Officer | Sale | Feb 27, 2024 | 102,306 |
| POMERANTZ ROGER J Director | Conversion of Exercise of derivative security | Nov 25, 2024 | 126,478 |
| ROJKJAER LISA Officer | Sale | Feb 27, 2023 | 48,087 |
| ROTHERA MARK Chief Executive Officer | Purchase | Dec 1, 2023 | 100,000 |
| ROYSTON IVOR Director | Conversion of Exercise of derivative security | Nov 25, 2024 | 858,340 |
Related Tickers
AEON AEON Biopharma, Inc.
0.1838
-3.31%
WINT Windtree Therapeutics, Inc.
0.2552
-5.09%
CYCC Cyclacel Pharmaceuticals, Inc.
0.4199
+1.21%
SNSE Sensei Biotherapeutics, Inc.
0.5125
-3.30%
ADTX Aditxt, Inc.
0.1699
+1.01%
ENVB Enveric Biosciences, Inc.
0.4000
-3.82%
SCPX Scorpius Holdings, Inc.
0.3823
+0.34%
SYRS Syros Pharmaceuticals, Inc.
0.2250
+7.14%
LYRA Lyra Therapeutics, Inc.
0.1955
-2.59%
CNSP CNS Pharmaceuticals, Inc.
0.1178
+1.55%